Skip to main content

Table 4 Positive rate and timing of anti-Eno and anti-Fba1 antibodies in non-neutropenic and neutropenic patients with candidemia [ n (%)]

From: Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia

Population (No. of subjects) Anti-Eno Anti-Fba1
Ab*(+) prior to BC(+) BC**(+) prior to Ab(+) Total Ab(+) prior to BC(+) BC(+) prior to Ab(+) Total
Non-neutropenia (90) 38 (42.2) 31 (34.4) 69 (76.7) 46 (51.1) 37 (41.1) 83 (92.2)
Neutropenia# (11) 3 (27.3) 1 (9.1) 4 (36.4)a 4 (36.4) 1 (9.1) 5 (45.5)b
Total (101) 41 (40.6) 32 (31.7) 73 (72.3) 50 (49.5) 38 (37.6) 88 (87.1)
  1. *Ab: antibody, ** BC: blood culture.
  2. #Neutropenia was defined as an absolute neutrophil count below 500 cells/mm3.
  3. a P = 0.005, for the comparison with the Non-neutropenia group.
  4. b P < 0.001, for the comparison with the Non-neutropenia group.